We are live on ! Find out more
PCH

Polar Capital Holdings Portfolio holdings

AUM $28.2B
1-Year Est. Return 115.26%
This Fund
S&P 500
This Quarter Est. Return
+19.21%
1 Year Est. Return
+115.26%
3 Year Est. Return
+356.87%
5 Year Est. Return
+474.2%
10 Year Est. Return
AUM
$16.5B
AUM Growth
Cap. Flow
+$15.4B
Cap. Flow %
93.32%
Top 10 Hldgs %
30.25%
Holding
321
New
321
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 35.76%
2 Healthcare 18.36%
3 Financials 13.71%
4 Communication Services 11.94%
5 Consumer Discretionary 7.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNH icon
101
UnitedHealth
UNH
$370B
$45.9M 0.28%
+130,860
New +$43.9M
MOH icon
102
Molina Healthcare
MOH
$10.3B
$45.6M 0.28%
+214,532
New +$44.3M
OXFD
103
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$44.9M 0.27%
+2,568,385
New +$36M
AXNX
104
DELISTED
Axonics, Inc. Common Stock
AXNX
$44.8M 0.27%
+897,689
New +$42.1M
ANSS
105
DELISTED
Ansys
ANSS
$44.1M 0.27%
+121,331
New +$40.6M
MMSI icon
106
Merit Medical Systems
MMSI
$5.32B
$38.2M 0.23%
+688,231
New +$35.5M
BIIB icon
107
Biogen
BIIB
$30.7B
$36.7M 0.22%
+150,000
New +$38.7M
CCXI
108
DELISTED
ChemoCentryx, Inc.
CCXI
$36M 0.22%
+581,194
New +$33.3M
SPLK
109
DELISTED
Splunk Inc
SPLK
$35.9M 0.22%
+211,584
New +$40.5M
JRVR icon
110
James River Group Holdings
JRVR
$217M
$35.6M 0.22%
+725,000
New +$35.1M
OPCH icon
111
Option Care Health
OPCH
$3.56B
$35M 0.21%
+2,239,506
New +$33.3M
C icon
112
Citigroup
C
$226B
$34.3M 0.21%
+556,794
New +$28.3M
HAE icon
113
Haemonetics
HAE
$4B
$34.3M 0.21%
+289,090
New +$31.1M
CHNGU
114
DELISTED
Change Healthcare Inc. Tangible Equity Units
CHNGU
$34.3M 0.21%
+535,000
New +$31.6M
NET icon
115
Cloudflare
NET
$107B
$32.8M 0.2%
+431,804
New +$28.3M
RVNC
116
DELISTED
Revance Therapeutics, Inc.
RVNC
$32.7M 0.2%
+1,154,734
New +$29.9M
CGNX icon
117
Cognex
CGNX
$11.3B
$32.2M 0.2%
+401,303
New +$29.2M
FAF icon
118
First American
FAF
$7.58B
$31M 0.19%
+600,000
New +$30.1M
BMRN icon
119
BioMarin Pharmaceuticals
BMRN
$12.4B
$30.7M 0.19%
+350,000
New +$27.7M
TMUS icon
120
T-Mobile US
TMUS
$190B
$30M 0.18%
+222,334
New +$27.5M
ELV icon
121
Elevance Health
ELV
$85.5B
$29.9M 0.18%
+93,222
New +$28.6M
ENOV icon
122
Enovis
ENOV
$1.53B
$29.7M 0.18%
+450,862
New +$26.4M
NVST icon
123
Envista
NVST
$4.52B
$29.3M 0.18%
+867,595
New +$25.2M
CNST
124
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$28.8M 0.17%
+1,000,000
New +$25.2M
RLI icon
125
RLI Corp
RLI
$5.89B
$28.6M 0.17%
+550,000
New +$26.4M

Similar funds

Polar Capital Holdings's Q4 2020 Portfolio in Review

Q4 2020 is the first quarter with a 13F filing on record for Polar Capital Holdings, which disclosed 321 positions worth $16.5B. Its ten largest holdings account for 30% of the portfolio.

Its largest position is Apple: 5,788,169 shares worth $768M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, followed by Healthcare and Financials.

  • Polar Capital Holdings's largest Q4 2020 buy was Apple: 5,788,169 shares worth $768M.
  • Polar Capital Holdings's ten largest holdings make up 30% of its $16.5B portfolio in Q4 2020.
  • Polar Capital Holdings disclosed 321 positions in Q4 2020, its first 13F filing on record.

Based on Polar Capital Holdings's 13F filing for Q4 2020, filed 16 Feb 2021.